RPRX
Royalty Pharma Plc
57.70$
-1.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | +14.1% | +3.0% | +22.0% | -0.8% | +6.3% | +39.4% | -7.3% | -10.1% | |
| – | -44.2% | -79.2% | +665,240.0% | +0.0% | -28.1% | -3.6% | -0.3% | -75.3% | +261.5% | -100.0% | – | |
| – | – | – | – | – | – | – | -55.0% | -11.2% | +8.6% | -0.6% | +12,267.5% | |
| – | -1.1% | -48.5% | -5,871.8% | – | – | – | -25.0% | +70.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | -83.5% | +891.9% | -132.1% | |
| – | – | – | – | -88.2% | +538.5% | +27.6% | -100.0% | +390,177.6% | +3.6% | -100.0% | – | |
| – | – | – | – | – | -809.8% | +28.1% | -32.2% | -45.0% | +101.4% | +29.2% | -39.7% | |
| – | – | – | – | +10.8% | -9.2% | -46.3% | -28.2% | +16.9% | +7.5% | +5.1% | +0.5% | |
| – | +1,856.5% | +0.0% | – | – | – | – | -104.0% | -70.0% | +111.5% | -24.6% | +434.5% | |
| – | – | – | – | -132.4% | +0.0% | – | +73.0% | -100.1% | +74,139.0% | – | -35.1% | |
| – | -30.6% | +2,719.6% | -4,385.6% | +1,018.9% | -13.6% | – | -74.1% | -345.3% | +127.4% | – | -428.4% | |
| – | – | – | – | – | -402.3% | – | -30.2% | -68.1% | -827.0% | – | -168.7% | |
| – | – | – | – | +14.1% | +3.0% | +153.8% | -52.3% | +107.4% | -28.6% | -7.3% | -10.1% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.